Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunization in the post tOPV-bOPV period: A multi-centric open label randomized controlled trial (India fractional dose IPV study) - WHO fIPV study

Next Previous
Trial Profile

Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunization in the post tOPV-bOPV period: A multi-centric open label randomized controlled trial (India fractional dose IPV study) - WHO fIPV study

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2017

At a glance

  • Drugs Poliovirus vaccine inactivated (Primary) ; Poliovirus vaccine inactivated (Primary) ; Poliovirus vaccine
  • Indications Poliomyelitis
  • Focus Pharmacodynamics
  • Sponsors Panacea Biotec

    • Most Recent Events

    • 07 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top